Share this
ERYTECH – $144 Million IPO
ZELTIQ Aesthetics to Sell to Allergan for $2.5 Billion
Cooley Advises on Nightstar + NuCana IPOs
Jazz Pharmaceuticals Acquisition of Redx Pharma's pan-RAF Inhibitor Program Valued up to $206 Million
X4 Pharmaceuticals in its Exclusive License Agreement with Abbisko Therapeutics
GENFIT SA in its Licensing and Collaboration Agreement with Terns Pharmaceuticals
Innate Pharma - $79 Million IPO
Therachon Sells to Pfizer for up to $810 Million
AN2 Therapeutics in its Exclusive License Agreement with Brii Biosciences
Celularity to Go Public Through SPAC Merger